BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Synteract, Inc. Announces New Vice President Of Medical And Regulatory Affairs


10/19/2005 5:10:06 PM

SAN DIEGO, Sept. 13 /PRNewswire/ -- Dr. Marilyn R. Carlson has joined Synteract as the Vice President of Medical & Regulatory Affairs, providing senior executive medical and regulatory guidance to the Company's clients.

Dr. Carlson is a graduate of Harvard (D.M.D.) and Case Western Reserve University (M.D.). She completed Internal Medicine at the Cleveland Clinic and is certified in Regulatory Affairs.

"We are fortunate to have a person of Dr. Carlson's caliber join our Organization. She brings over 13 years of pharmaceutical field experience to Synteract having worked across multiple therapeutic areas in the biotechnology, pharmaceutical, pharmacogenomic, medical device and managed care industries," said Ellen Morgan, President and Chief Executive Officer of Synteract, Inc. "Her knowledge and expertise in Medical, Regulatory and Clinical Affairs will be a valuable resource for Synteract's rapid growth and will expand the medical and regulatory services Synteract provides for their clients, particularly in early phase studies and overall strategic clinical program planning."

Dr. Carlson was previously with Procter & Gamble, XOMA, ISTA Pharmaceuticals and Prometheus Laboratories. She is President of entreMeDica, Inc., a medical consulting company.

About Synteract Inc.

Established in 1995, Synteract is a privately held, full-service contract research organization, dedicated to meeting the various needs of biotechnology, biomedical, pharmaceutical, and drug industry firms. Based in Carlsbad, CA, with a branch office in Pennsylvania, the Company provides expertise in a wide range of therapeutic areas and maintains a wealth of knowledge in oncology, ophthalmology, HIV, sexual dysfunction, cardiovascular disease, and pain. Since 2000, it has been a key development shop for web, wireless and voice data solutions that speed the completion of clinical trials and assist in access to clinical trials information. This includes technologies such as electronic data capture (EDC), interactive voice response systems (IVRS), and automated safety tracking and reporting. For information, please visit us at or call (760) 268.8200. http://www.synteract.com/

For more information please contact: Ellen Morgan, +1-760-268-8200 emorgan@synteract.com.

Synteract Inc.

CONTACT: Ellen Morgan of Synteract Inc, +1-760-268-8200emorgan@synteract.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES